Exelixis
EXEL
#1589
Rank
โ‚ฌ12.06 B
Marketcap
48,02ย โ‚ฌ
Share price
2.89%
Change (1 day)
27.75%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company